"Significant efficacy both by Investigator’s and patients’ viewpoints"
by Mansouri P. et al. 2015. British Journal of Dermatology
Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial
Mansouri P. et al.
British Journal of Dermatology, 2015
Melasma is a difficult-to-treat hyperpigmentary disorder. While cysteamine is a known potent depigmenting agent, the study conducted by Professor Parvin Mansouri of the Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Iran, has demonstrated significant efficacy of Cysteamine Cream® in the treatment of patients with epidermal melasma.